Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Frere

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
World Journal of Gastroenterology|May 27, 2021
Burden of venous thromboembolism in patients with pancreatic cancerCorinne Frere
The Lancet. Haematology|December 19, 2018
The best direct-acting oral anticoagulant for treatment of venous thromboembolism?Corinne Frere, Dominique Farge
F1000Research|July 13, 2019
Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challengesDominique Farge, Corinne Frere
Blood Advances|January 15, 2026
Weighing the evidence on cabozantinib and thrombotic riskFlorian Moik, Corinne Frere
Thrombosis and Haemostasis|September 10, 2016
Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patientsCorinne Frere, Dominique Farge
The New England Journal of Medicine|July 6, 2018
Edoxaban for Cancer-Associated Venous ThromboembolismCorinne Frere, Monique Dufilho
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
Commentary on "Risk of venous thromboembolism after COVID-19 vaccination"Corinne Frere, Joe-Elie Salem
Expert Review of Hematology|April 1, 2016
Prophylaxis of venous thromboembolism in cancer patientsCorinne Frere, Ludovic Doucet, Dominique Farge
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Reduced-dose direct oral anticoagulants for the secondary prevention of venous thromboembolism: finding the sweet spotBenjamin Crichi, Maxime Delrue, Corinne Frere
JACC. Cardiovascular Interventions|August 7, 2017
Platelet Reactivity: Back to the Future?Laurent Bonello, Marc Laine, Corinne Frere
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
World Journal of Gastroenterology|May 27, 2021
Burden of venous thromboembolism in patients with pancreatic cancerCorinne Frere
The Lancet. Haematology|December 19, 2018
The best direct-acting oral anticoagulant for treatment of venous thromboembolism?Corinne Frere, Dominique Farge
F1000Research|July 13, 2019
Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challengesDominique Farge, Corinne Frere
Blood Advances|January 15, 2026
Weighing the evidence on cabozantinib and thrombotic riskFlorian Moik, Corinne Frere
Thrombosis and Haemostasis|September 10, 2016
Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patientsCorinne Frere, Dominique Farge
The New England Journal of Medicine|July 6, 2018
Edoxaban for Cancer-Associated Venous ThromboembolismCorinne Frere, Monique Dufilho
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
Commentary on "Risk of venous thromboembolism after COVID-19 vaccination"Corinne Frere, Joe-Elie Salem
Expert Review of Hematology|April 1, 2016
Prophylaxis of venous thromboembolism in cancer patientsCorinne Frere, Ludovic Doucet, Dominique Farge
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Reduced-dose direct oral anticoagulants for the secondary prevention of venous thromboembolism: finding the sweet spotBenjamin Crichi, Maxime Delrue, Corinne Frere
JACC. Cardiovascular Interventions|August 7, 2017
Platelet Reactivity: Back to the Future?Laurent Bonello, Marc Laine, Corinne Frere
Pageof 11